Patents by Inventor Andrew K. Koski

Andrew K. Koski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stabilized pharmaceutical dosage forms comprising atrasentan
    Patent number: 10016393
    Abstract: The present disclosure relates to: (a) methods of using stabilized pharmaceutical dosage forms comprising atrasentan, or a pharmaceutically acceptable salt thereof, and, optionally, another therapeutic agent to treat type 2 diabetes, microalbuminuria or macroalbuminuria; and (b) methods for the preparation of such pharmaceutical dosage forms.
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: July 10, 2018
    Assignee: AbbVie Inc.
    Inventors: Ye Huang, Andrew K. Koski, Katherine E. Peterson
  • STABILIZED PHARMACEUTICAL DOSAGE FORMS COMPRISING ATRASENTAN
    Publication number: 20160250186
    Abstract: The present disclosure relates to: (a) methods of using stabilized pharmaceutical dosage forms comprising atrasentan, or a pharmaceutically acceptable salt thereof, and, optionally, another therapeutic agent to treat type 2 diabetes, microalbuminuria or macroalbuminuria; and (b) methods for the preparation of such pharmaceutical dosage forms.
    Type: Application
    Filed: May 13, 2016
    Publication date: September 1, 2016
    Inventors: Ye Huang, Andrew K. Koski, Katherine E. Peterson
  • Stabilized pharmaceutical dosage forms comprising atrasentan
    Patent number: 9364458
    Abstract: The present disclosure relates to: (a) stabilized pharmaceutical dosage forms comprising atrasenstan, or a pharmaceutically acceptable salt thereof, and, optionally, another therapeutic agent; (b) methods of using such pharmaceutical dosage forms to treat nephropathy, chronic kidney disease, and/or other conditions; (c) kits comprising such pharmaceutical dosage forms and, optionally, a second pharmaceutical dosage form comprising another therapeutic agent; (d) methods for the preparation of such pharmaceutical dosage forms; and (e) pharmaceutical dosage forms prepared by such methods.
    Type: Grant
    Filed: July 7, 2014
    Date of Patent: June 14, 2016
    Assignee: AbbVie Inc.
    Inventors: Ye Huang, Andrew K. Koski, Katherine E. Peterson
  • STABILIZED PHARMACEUTICAL DOSAGE FORMS COMPRISING ATRASENTAN
    Publication number: 20150011602
    Abstract: The present disclosure relates to: (a) stabilized pharmaceutical dosage forms comprising atrasenstan, or a pharmaceutically acceptable salt thereof, and, optionally, another therapeutic agent; (b) methods of using such pharmaceutical dosage forms to treat nephropathy, chronic kidney disease, and/or other conditions; (c) kits comprising such pharmaceutical dosage forms and, optionally, a second pharmaceutical dosage form comprising another therapeutic agent; (d) methods for the preparation of such pharmaceutical dosage forms; and (e) pharmaceutical dosage forms prepared by such methods.
    Type: Application
    Filed: July 7, 2014
    Publication date: January 8, 2015
    Applicant: ABBVIE INC.
    Inventors: Ye Huang, Andrew K. Koski, Katherine E. Peterson